VELIN-PHARMA A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About VELIN-PHARMA A/S
VELIN-PHARMA A/S (CVR number: 33026013) is a company from FREDENSBORG. The company recorded a gross profit of -3.4 kDKK in 2023. The operating profit was -3.4 kDKK, while net earnings were 12.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 38.7 %, which can be considered excellent and Return on Equity (ROE) was 29.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 93.4 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. VELIN-PHARMA A/S's liquidity measured by quick ratio was 15 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 278.65 | 150.16 | 439.91 | 161.40 | -3.44 |
EBIT | 278.65 | 150.16 | 439.91 | 161.40 | -3.44 |
Net earnings | 3 483.81 | 5 954.07 | 3 117.18 | 5 547.26 | 12 695.30 |
Shareholders equity total | 22 170.22 | 28 124.29 | 31 241.47 | 36 788.73 | 49 484.02 |
Balance sheet total (assets) | 22 714.90 | 29 882.11 | 32 076.04 | 38 448.47 | 52 976.08 |
Net debt | -16 868.11 | -23 786.70 | -26 989.28 | -34 349.84 | -50 300.56 |
Profitability | |||||
EBIT-% | |||||
ROA | 20.5 % | 29.0 % | 12.9 % | 23.3 % | 38.7 % |
ROE | 17.1 % | 23.7 % | 10.5 % | 16.3 % | 29.4 % |
ROI | 20.8 % | 30.3 % | 13.5 % | 24.2 % | 41.0 % |
Economic value added (EVA) | 105.17 | -44.30 | 218.95 | 5.92 | - 125.24 |
Solvency | |||||
Equity ratio | 97.6 % | 94.1 % | 97.4 % | 95.7 % | 93.4 % |
Gearing | 0.6 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 37.7 | 15.8 | 35.8 | 23.1 | 15.0 |
Current ratio | 38.1 | 15.9 | 36.2 | 23.2 | 15.2 |
Cash and cash equivalents | 17 001.96 | 23 786.70 | 26 989.28 | 34 349.84 | 50 300.56 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | AA | AA | AA | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.